Translational Medicine Academy

Startseite
Schweiz
Basel
Translational Medicine Academy

BRIDGING THE GAPS BETWEEN KNOWLEDGE AND CARE – FASTER

TMA is a nonprofit advancing science to care.

We connect experts to speed clinical adoption and move innovation from lab to bedside through collaboration and translational research.

08/06/2026

At ECO 2026, the accepted symposium presented by the Alliance explores a shift toward more integrated thinking in obesity-related HFpEF, where cardiometabolic interactions increasingly define both disease progression and therapeutic response.

From Guidelines to Person-Centred Integrated Care: Improving Outcomes for patients living with or at risk of obesity-related HFpEF reflects the growing recognition that heart failure phenotypes cannot be managed in isolation, particularly as obesity continues to shape risk trajectories across the cardiometabolic spectrum. The discussion highlights the need for care models that move beyond guideline application alone, toward more personalised, integrated approaches in routine clinical practice.

e-SPACE Heart Failure 2026 continues this scientific direction, focusing on how evolving evidence can be translated into practical strategies across heart failure phenotypes.

Continue the discussion in October 2026: https://www.tmacademy.org/
23–24 October 2026 | Virtual Congress

05/06/2026

Heart failure care continues to evolve, but the real challenge remains consistent implementation of guideline-directed therapy across the full spectrum of disease.

Updates in Heart Failure 2026 brings this focus to Stockholm this December, convening leading experts to examine how evidence can be translated into practice more effectively and consistently across clinical settings.

Organized by Karolinska Institute, under the guidance of its scientific leadership and chaired by Professor Gianluigi Savarese, the congress continues its commitment to bridging evidence and action in heart failure care.

14–15 December 2026 | Stockholm, Sweden
Registrations are now open: https://heartfailurecongress.tmacademy.org/

30/05/2026

Heart failure evidence is no longer the challenge. The challenge is what happens after the evidence is published.

In real-world practice, clinicians are often faced with complex patients, competing priorities, and gaps between guideline recommendations and what is actually achievable at the bedside. This is where implementation becomes the real determinant of outcomes.

e-SPACE Heart Failure was designed around this gap, focusing on how contemporary heart failure evidence can be translated into practical clinical decisions. Through expert-led discussions, the programme addresses how therapies are initiated, adjusted, and prioritised in patients who rarely fit trial populations.

It is not just about what the guidelines say, but how they are applied when clinical reality is more complex than the evidence tables.

Missed the sessions? The full programme is now available on demand: https://www.espace-hf.org/2025/

27/05/2026

Heart failure is not an isolated cardiac condition. It is a complex, multi-system syndrome that often intersects with renal dysfunction, metabolic disease, and a wide spectrum of patient comorbidities, all of which shape outcomes and treatment pathways.

This is why integrated, guideline-driven education is essential in modern HF care. e-SPACE Heart Failure is a global virtual initiative designed to support clinicians in translating evidence into practice, with a strong focus on real-world management of heart failure alongside renal and metabolic comorbidities.

Through expert-led, practical learning, the programme explores contemporary guideline updates, patient phenotyping, and multidisciplinary approaches that reflect everyday clinical complexity.

On-demand sessions are now available. If you missed it, you can still explore the full experience and expand your HF knowledge via the TMA platform: https://espacehf.tmacademy.org/

25/05/2026

Dr. Alicia Uijl discusses the growing burden of heart failure in an ageing, multimorbid population and how increasing clinical complexity is driving the need for new analytical approaches.

The session highlights the role of artificial intelligence in leveraging large volumes of routinely collected electronic health record data to better understand heart failure phenotypes, risk, and outcomes in clinical practice.

She further outlines key machine learning approaches, including supervised and unsupervised learning, and their applications in risk prediction, decision support, and data-driven classification in heart failure care.

Watch on demand: https://lnkd.in/gcND4mea

23/05/2026

Heart failure care evolves when guidelines move beyond publications and into daily clinical decision-making.

e-SPACE Heart Failure 2026 brings together a world-leading international faculty to explore GDMT implementation, patient profiling, emerging therapies, devices, and real-world strategies designed to improve better patient outcomes across the heart failure spectrum.

Save the Date: 23–24 October 2026
Join a global virtual programme translating evidence into practice: https://tinyurl.com/2unz26ce

20/05/2026

Our session at was a tremendous success, bringing together cardiologists and heart failure experts for a high-level EBAC-accredited educational session on Innovative Approaches in the Management of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) in the Era of Guideline-Directed Medical Therapy (GDMT).

Strong engagement and full attendance reflected the growing clinical focus on advancing heart failure care beyond GDMT, with discussions centred on emerging therapeutic and device-based strategies, including interatrial shunt therapy and device management approaches.

The session featured insights from an international faculty addressing unmet clinical needs, patient selection considerations, and the balance of risks and benefits when integrating novel interventions into modern HFrEF management.

Thank you to all attendees and faculty for contributing to an engaging and impactful scientific exchange at HFA 2026.

Stay tuned for session highlights and upcoming educational updates.
https://www.tmacademy.org/

20/05/2026

LDL-C management continues to present a significant gap in primary cardiovascular prevention, despite its well-established role in long-term risk reduction.

This upcoming live webinar brings together international experts to explore how earlier intervention and more intensive lipid-lowering strategies may reshape preventive care in clinical practice.

Key focus areas include the LDL-C treatment gap, the benefits of early LDL-C lowering, and practical implementation of a “strike early, strike strong” approach, alongside the role of single-pill combinations in improving adherence and outcomes.

Register to join the discussion: https://www.p2pmd.net/cmvd-ice-2

18/05/2026

In this Meet the Experts session from e-SPACE Cardio-Renal-Metabolic 2026, Prof. Carol Po***ck and Prof. Mark Petrie explore why earlier diagnosis and intervention in CKM syndrome is becoming increasingly critical in improving patient outcomes.

The discussion highlights the growing shift toward CKM staging, from early metabolic risk through to overt cardiovascular and renal disease, and how this framework is reshaping risk identification and clinical decision-making in heart failure and diabetes populations.

With insights into early screening strategies and the importance of timely heart failure detection, the session reinforces a key message: earlier action changes outcomes.

Missed it? Watch on demand: https://www.espace-crm.org/2026

18/05/2026

Dyslipidemia remains a major driver of cardiovascular risk, with persistent gaps in LDL-C control in primary prevention.

Join leading international experts for a focused scientific discussion on whether current strategies are sufficient, and how earlier, more intensive lipid-lowering approaches may improve long-term outcomes.

Key topics include:
• The LDL-C treatment gap
• Clinical value of early LDL-C lowering
• A proactive “strike early, strike strong” approach
• Role of single-pill combination strategies in practice

Register now to secure your place: https://www.p2pmd.net/cmvd-ice-2

Adresse

Picasso Platz 8
Basel
4052

Webseite

https://www.tmacademy.org/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Translational Medicine Academy erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.